This paper summarises in a short and concise manner the potential benefit of financial analysis to a prospective investor. The company ADVANCED MEDICAL SOLUTIONS GROUP PLC (AMS) was chosen at random – figures used are from the group as a whole.
In section (i.), I will measure the companies past performances related to Financial Statements (F/S) and identify its strengths and weaknesses associated with this information.
In section (ii.), I will comment on the limitation and usefulness of ROCE vs. EVA & MVA.
Table of Contents
1.0 Question 1
a. Abstract
b. Introduction- Business Statistics of Company
1.i Advanced Medical Solutions Group (AMS) plc – Corporate Analysis
1.i.a Corporate Performance over Past two Years
1.i.b Control of Working Capital/Liquidity
1.i.c Funding/Capital Structure of AMS
1.i.d Implications of Ratio’s – Comments to Investor
1.ii Judging the Profitability of a Company - ROCE Ratio and It’s Limitations
Alternative or other Performance Measurements – Comments on EVA & MVA
3.0 Appendix
3.a Copy of Annual Report 2002
3.b Financial Charts
3.c Financial Accounts
3.c.i Profit & Loss (Income Statement)
3.c.ii Balance Sheet
3.c.iii Cash Flow Statement
3.d Benchmark SIC codes
Objectives & Core Topics
This paper aims to provide a concise financial analysis of the Advanced Medical Solutions Group (AMS) plc to assist potential investors in evaluating the company's past performance and future investment potential. The study utilizes financial statements to identify key corporate strengths and weaknesses, while also critically examining the utility of specific performance metrics like ROCE compared to modern alternatives such as EVA and MVA.
- Evaluation of corporate performance using profitability and liquidity ratios.
- Analysis of the company's capital structure and leverage position.
- Stock performance review and investment implication assessment.
- Critical discussion on profitability measurement limitations (ROCE vs. EVA/MVA).
- Strategic framework integration via the Balanced Scorecard and benchmarking.
Excerpt from the Book
1.i.b Control of Working Capital/Liquidity
Financial strength looks at the business risk and liquidity, which is about shot-term viability of a company. A concern for investors and analysts are a company’s ability to meet its maturing and on-going obligations. Working capital has an effect on incremental cash flows especially if net working capital changes from previous levels (factors are especially, stock movement, trade debtors and trade creditors).
The following ratios in table 3 will give us a good inside of AMS of its control of working capital and it’s liquidity position:
Summary of Chapters
1.0 Question 1: Provides the foundation for the analysis, including an abstract and an introduction to the business statistics of the chosen company.
a. Abstract: Outlines the purpose of the paper, focusing on the potential benefits of financial analysis for prospective investors in AMS.
b. Introduction- Business Statistics of Company: Presents a high-level overview of the company, including industry sector, products, and key market figures.
1.i Advanced Medical Solutions Group (AMS) plc – Corporate Analysis: An in-depth evaluation of the company’s operational performance and financial standing.
1.i.a Corporate Performance over Past two Years: Utilizes profitability ratios to examine the return on investment and market performance over the 2001-2002 period.
1.i.b Control of Working Capital/Liquidity: Analyzes the company’s short-term viability and ability to meet financial obligations using liquidity ratios.
1.i.c Funding/Capital Structure of AMS: Examines the leverage and gearing of the company to understand how it is financed.
1.i.d Implications of Ratio’s – Comments to Investor: Translates financial technicalities into actionable advice for potential shareholders.
1.ii Judging the Profitability of a Company - ROCE Ratio and It’s Limitations: Critically evaluates the Return on Capital Employed metric in the context of company performance.
Alternative or other Performance Measurements – Comments on EVA & MVA: Explores advanced metrics as more effective alternatives to traditional profitability ratios.
3.0 Appendix: Contains supporting documents, financial charts, and detailed accounting data.
3.a Copy of Annual Report 2002: Reference to the source material used for the analysis.
3.b Financial Charts: Visual representations of working capital and cash outflows.
3.c Financial Accounts: Detailed breakdown of the company's fiscal reports.
3.c.i Profit & Loss (Income Statement): Detailed income statement data for the analyzed period.
3.c.ii Balance Sheet: Statement of the company's financial position at year-end.
3.c.iii Cash Flow Statement: Overview of cash movements and financing activities.
3.d Benchmark SIC codes: Industry-standard comparison data for sectoral performance.
Keywords
Financial Analysis, Advanced Medical Solutions, Profitability Ratios, Working Capital, Liquidity, Capital Structure, ROCE, EVA, MVA, Balanced Scorecard, Benchmarking, Investor Relations, Corporate Performance, Shareholder Equity, Asset Management.
Frequently Asked Questions
What is the primary focus of this assignment?
This assignment provides a comprehensive financial analysis of the Advanced Medical Solutions Group (AMS) to help prospective investors understand the company's financial health.
What are the core thematic fields covered in the study?
The study covers corporate performance, liquidity control, capital structure, investment ratios, and the theoretical limitations of traditional profitability measures.
What is the central research goal?
The goal is to determine the potential benefit of financial analysis for an investor by identifying company strengths and weaknesses and assessing if AMS shares represent a viable investment.
Which scientific or analytical methods are applied?
The paper utilizes ratio analysis (profitability, liquidity, leverage, investment), standard industrial benchmarking (SIC codes), and critical evaluation of management accounting frameworks.
What topics are discussed in the main section?
The main section deals with corporate performance, working capital management, funding structures, and a comparative analysis of ROCE against EVA and MVA.
How can the paper be summarized by its keywords?
It is characterized by terms such as Financial Analysis, Liquidity, Capital Structure, ROCE, EVA, and Corporate Performance.
How does the author evaluate the ROCE ratio?
The author highlights the limitations of ROCE, such as its failure to account for risk and the potential for distortion through creative accounting or non-comparable asset valuations.
What is the role of the Balanced Scorecard mentioned in the text?
The Balanced Scorecard is presented as a strategic management framework that combines financial and non-financial measures to translate company vision and strategy into tangible goals.
What is the significance of the SIC codes included in the appendix?
The SIC codes provide an industry-standard benchmark, allowing the author to compare AMS’s performance figures against those of similar surgical and medical manufacturing companies.
- Quote paper
- MBA Andreas Keller (Author), 2003, Managerial Accounting - Managing Financial Resources, Munich, GRIN Verlag, https://www.hausarbeiten.de/document/178458
